Food and Drugs Authority (FDA) has cautioned the general public against the use of two eyedrop products called Ezricare Artificial Tears and Delsam Pharma’s Artificial Tears owned by Global Pharma.
The warning, according to the authority, is follows recent major incidence of contamination of two brands eyedrops in the United States.
FDA in a public notice, said the US Centre for Disease Control and Prevention (CDC) classified the incident as an outbreak and found the products contain the drug-resistant bacteria pseudomonas aeruginosa.
Manufacturer, of the product, Global Pharma, who have since issued a voluntary recall of the products is reported to have led to three deaths and vision loss in eight patients.
FDA is thus noting that the “product are not registered with the Ghana FDA and therefore they should not be commercially available on the Ghanaian market.
However, FDA advised the public who may be in possession of these drugs through other means to immediately stop using the recalled products, Ezricare Artificial Tears and Delsam Pharma’s Artificial Tears, and submit them to any of the FDA offices nationwide,” parts of the public notice called-on Ghanaians.
On that score it is asking persons who have accidentally used the products and experiencing any symptoms should contact nor attend to a healthcare professional immediately for assistant.
Reported symptoms of the use of Ezricare Artificial Tears and Delsam Pharma’s Artificial Tears, include yellow, green or clear discharge from the eye, eye pain or discomfort, redness, feeling of a substance on the eye, increased sensitivity to light and blurred vision.
The FDA assured the general public that it is “taking all necessary measures to ensure that only safe and effective medical products are available in Ghana.”
Read attached the FDA’s full statement
